Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
High-sensitivity Troponin in Cardiac Surgery
Author(s): Cuilin Zhu , Xiaomeng Wang , Xiao Liu , et al Added: 2 months ago

MI/ACS
Efficacy and Safety of LAAO during Cardiac Surgery to Prevent Stroke
Author(s): Reynald Evan R Tugade , Billy Joseph David , Clara S Tolentino Added: 1 year ago

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
TCT Middle East 25: Minimally Invasive Surgery
Author(s): Rania Hammami , Uthman Aluthman Added: 10 months ago
TCT Middle East 2025 — We are joined by Prof Rania Hammami and Dr Uthman Aluthman as they discuss the key takeaways for minimally invasive surgery from the conference.The specialists provide insights on evolving definitions and expanding applications of minimally invasive cardiac surgical techniques. They address practical considerations regarding patient selection, recovery trajectories, and… View more

Intervention
TAVR vs Surgery: No Difference at 7 Years in Low-Risk AS
Added: 1 week ago Source:  Transcatheter Academy
Seven-year follow-up data from the PARTNER 3 trial shows no significant difference in key outcomes between transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement (SAVR) for low-risk patients with severe, symptomatic aortic stenosis.¹ This long-term assessment provides further insight into valve durability and clinical outcomes, building on previous 5-year data which… View more

Intervention
TCT 24: The MATTERHORN Trial
Author(s): Stephan Baldus Added: 1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more

Heart Failure

Intervention
ESC 24: The MATTERHORN Trial
Author(s): Volker Rudolph , Stephan Baldus Added: 1 year ago
ESC Congress 2024 — TEER non-inferior to mitral valve surgery with regard to death, HF rehospitalisation, stroke, reintervention of LVAD at one year.Dr Volker Rudolph (Heart and Diabetes Center NRW, DE) and Prof Stephan Baldus (University Hospital of Köln, DE) joins us in London to discuss the MATTERHORN trial (NCT02371512; University Hospital of Köln).This multicenter, randomized controlled… View more

Intervention
CNAP and Thermodilution Agreement in Estimating Haemodynamic Parameters
Author(s): Juxerez Maria B Sulit , Armand Delo Tan Added: 11 months ago

Vascular Disease and Surgery

Heart Failure
AHA 24: The SELECT Trial
Author(s): Subodh Verma Added: 1 year ago
AHA Conference 2024 - Outcomes of SELECT show that semaglutide treatment in obese or overweight patients with prior history of coronary artery bypass graft (CABG) surgery reduces the risk of cardiovascular events.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us onsite at AHA Conference to discuss the findings from SELECT (NCT03574597).SELECT is a randomized, double-blind, placebo… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
The European Association for Cardio-Thoracic Surgery was founded in 1986 as a European organisation devoted to the practice of cardio-thoracic surgery. Membership has now spread all over the world with 4000 active members including surgeons, perfusionists and allied health professionals.The mission of the Association is to advance education in the field of cardiac, thoracic and vascular… View more
Viewpoint on the 2025 European Society of Cardiology/ European Association for Cardio-Thoracic Surgery Guidelines on the Management of Valvular Heart Disease
Author(s): Xiayan Shen , See Hooi Ewe Added: 3 months ago

Guidelines & Statements

Imaging & Diagnostics